Ginsenoside Rd attenuates mitochondrial permeability transition and cytochrome c release in isolated spinal cord mitochondria: Involvement of kinase-mediated pathways

International Journal of Molecular Sciences

Volumn 15, Issue 6, 2014, Pages 9859-9877

  Zhou, Jin Song ^a,d   Wang, Jiang Feng ^b   He, Bao Rong ^c   Cui, Yong Sheng ^b   Fang, Xiang Yi ^c   Ni, Jian Long ^a   Chen, Jie ^a   Wang, Kun Zheng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHAANXI UNIVERSITY OF CHINESE MEDICINE   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^d Department of Pharmacy Xi'an No 4 Hospital   (China)

Author keywords

Cytochrome c; Mitochondria; Protein kinases; Spinal cord injury

Indexed keywords

BISINDOLYLMALEIMIDE; CALCIUM ION; CYTOCHROME C; GINSENOSIDE RD; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; WORTMANNIN; CALCIUM; CARRIER PROTEIN; GINSENOSIDE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NEUROPROTECTIVE AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUOROMETER; GINSENG; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; MOUSE; NONHUMAN; PARAPLEGIA; PROTEIN PHOSPHORYLATION; SPINAL CORD INJURY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; MITOCHONDRION; PANAX; PERMEABILITY; SPINE;

ANIMALS; CALCIUM; CYTOCHROMES C; GINSENOSIDES; HYDROGEN PEROXIDE; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NADP; NEUROPROTECTIVE AGENTS; PANAX; PERMEABILITY; SPINE;

EID: 84901932897     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15069859     Document Type: Article

References (65)

1. Svensson, L.G.; Crawford, E.S.; Hess, K.R.; Coselli, J.S.; Safi, H.J. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J. Vasc. Surg. 1993, 17, 357-368.
2. Zurita, M.; Aguayo, C.; Bonilla, C.; Otero, L.; Rico, M.; Rodriguez, A.; Vaquero, J. The pig model of chronic paraplegia: A challenge for experimental studies in spinal cord injury. Prog. Neurobiol. 2012, 97, 288-303.
3. Chiesa, R.; Melissano, G.; Civilini, E.; de Moura, M.L.; Carozzo, A.; Zangrillo, A. Ten years experience of thoracic and thoracoabdominal aortic aneurysm surgical repair: lessons learned. Ann. Vasc. Surg. 2004, 18, 514-520.
4. Etz, C.D.; Homann, T.M.; Luehr, M.; Kari, F.A.; Weisz, D.J.; Kleinman, G.; Plestis, K.A.; Griepp, R.B. Spinal cord blood flow and ischemic injury after experimental sacrifice of thoracic and abdominal segmental arteries. Eur. J. Cardiothorac. Surg. 2008, 33, 1030-1038.
5. Chang, C.K.; Chuter, T.A.; Reilly, L.M.; Ota, M.K.; Furtado, A.; Bucci, M.; Wintermark, M.; Hiramoto, J.S. Spinal arterial anatomy and risk factors for lower extremity weakness following endovascular thoracoabdominal aortic aneurysm repair with branched stent-grafts. J. Endovasc. Ther. 2008, 15, 356-362.
6. Backes, W.H.; Nijenhuis, R.J.; Mess, W.H.; Wilmink, F.A.; Schurink, G.W.; Jacobs, M.J. Magnetic resonance angiography of collateral blood supply to spinal cord in thoracic and thoracoabdominal aortic aneurysm patients. J. Vasc. Surg. 2008, 48, 261-271.
7. Ogino, H.; Sasaki, H.; Minatoya, K.; Matsuda, H.; Yamada, N.; Kitamura, S. Combined use of adamkiewicz artery demonstration and motor-evoked potentials in descending and thoracoabdominal repair. Ann. Thorac. Surg. 2006, 82, 592-596.
8. Jacobs, M.J.; Mess, W.; Mochtar, B.; Nijenhuis, R.J.; Statius van Eps, R.G.; Schurink, G.W. The value of motor evoked potentials in reducing paraplegia during thoracoabdominal aneurysm repair. J. Vasc. Surg. 2006, 43, 239-246.
9. Melissano, G.; Chiesa, R. Advances in imaging of the spinal cord vascular supply and its relationship with paraplegia after aortic interventions. Eur. J. Vasc. Endovasc. Surg. 2009, 38, 567-577.
10. Silver, J.; Miller, J.H. Regeneration beyond the glial scar. Neuroscience 2004, 5, 146-156.
11. Saxena, P.; Abu Hasan, F.; Merry, C. Spinal cord ischemia following coronary artery bypass surgery. J. Card. Surg. 2012, 27, 45-46.
12. De Haan, P.; Kalkman, C.J.; Jacobs, M.J. Pharmacologic neuroprotection in experimental spinal cord ischemia: A systematic review. J. Neurosurg. Anesthesiol. 2001, 13, 3-12.
13. Ahn, Y.H.; Lee, G.; Kang, S.K. Molecular insights of the injured lesions of rat spinal cords: Inflammation, apoptosis, and cell survival. Biochem. Biophys. Res. Commun. 2006, 348, 560-570.
14. Genovese, T.; Cuzzocrea, S. Role of free radicals and poly (ADP-ribose) polymerase-1 in the development of spinal cord injury: New potential therapeutic targets. Curr. Med. Chem. 2008, 15, 477-487.
15. Cassina, P.; Cassina, A.; Pehar, M.; Castellanos, R.; Gandelman, M.; de Leon, A.; Robinson, K.M.; Mason, R.P.; Beckman, J.S.; Barbeito, L. et al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J. Neurosci. 2008, 28, 4115-4122.
16. Zhou, Y.F.; Li, L.; Feng, F.; Yuan, H.; Gao, D.K.; Fu, L.A.; Fei, Z. Osthole attenuates spinal cord ischemia-reperfusion injury through mitochondrial biogenesis-independent inhibition of mitochondrial dysfunction in rats. J. Surg. Res. 2013, 185, 805-814.
17. Zhu, J.W.; Chen, T.; Guan, J.; Liu, W.B.; Liu, J. Neuroprotective effects of allicin on spinal cord ischemia-reperfusion injury via improvement of mitochondrial function in rabbits. Neurochem. Int. 2012, 61, 640-648.
18. Fu, J.; Fan, H.B.; Guo, Z.; Wang, Z.; Li, X.D.; Li, J.; Pei, G.X. Salvianolic acid B attenuates spinal cord ischemia-reperfusion-induced neuronal injury and oxidative stress by activating the extracellular signal-regulated kinase pathway in rats. J. Surg. Res. 2014, 188, 222-230.
19. Jia, L.; Zhao, Y. Current evaluation of the millennium phytomedicine-ginseng (I): Etymology, pharmacognosy, phytochemistry, market and regulations. Curr. Med. Chem. 2009, 16, 2475-2484.
20. Peng, L.; Sun, S.; Xie, L.H.; Wicks, S.M.; Xie, J.T. Ginsenoside Re: Pharmacological effects on cardiovascular system. Cardiovasc. Ther. 2012, 30, 183-188.
21. Lu, J.M.; Yao, Q.; Chen, C. Ginseng compounds: An update on their molecular mechanisms and medical applications. Curr. Vasc. Pharmacol. 2009, 7, 293-302.
22. Christensen, L.P.; Jensen, M. Biomass and content of ginsenosides and polyacetylenes in American ginseng roots can be increased without affecting the profile of bioactive compounds. J. Nat. Med. 2009, 63, 159-168.
23. Christensen, L.P. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv. Food Nutr. Res. 2009, 55, 1-99.
24. Ye, R.; Zhao, G.; Liu, X. Ginsenoside Rd for acute ischemic stroke: translating from bench to bedside. Expert Rev. Neurother. 2013, 13, 603-613.
25. Zhang, C.; Du, F.; Shi, M.; Ye, R.; Cheng, H.; Han, J.; Ma, L.; Cao, R.; Rao, Z.; Zhao, G. Ginsenoside Rd protects neurons against glutamate-induced excitotoxicity by inhibiting Ca2+ influx. Cell. Mol. Neurobiol. 2012, 32, 121-128.
26. Ye, R.; Han, J.; Kong, X.; Zhao, L.; Cao, R.; Rao, Z.; Zhao, G. Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. Biol. Pharm. Bull. 2008, 31, 1923-1927.
27. Ye, R.; Li, N.; Han, J.; Kong, X.; Cao, R.; Rao, Z.; Zhao, G. Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci. Res. 2009, 64, 306-310.
28. Ye, R.; Kong, X.; Yang, Q.; Zhang, Y.; Han, J.; Zhao, G. Ginsenoside Rd attenuates redox imbalance and improves stroke outcome after focal cerebral ischemia in aged mice. Neuropharmacology 2011, 61, 815-824.
29. Ye, R.; Kong, X.; Yang, Q.; Zhang, Y.; Han, J.; Li, P.; Xiong, L.; Zhao, G. Ginsenoside rd in experimental stroke: Superior neuroprotective efficacy with a wide therapeutic window. Neurotherapeutics 2011, 8, 515-525.
30. Ye, R.; Zhang, X.; Kong, X.; Han, J.; Yang, Q.; Zhang, Y.; Chen, Y.; Li, P.; Liu, J.; Shi, M.; et al. Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience 2011, 178, 169-180.
31. Ye, R.; Yang, Q.; Kong, X.; Han, J.; Zhang, X.; Zhang, Y.; Li, P.; Liu, J.; Shi, M.; Xiong, L.; Zhao, G. Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats. Neurochem. Int. 2011, 58, 391-398.
32. Brustovetsky, N.; Dubinsky, J.M. Limitations of cyclosporin A inhibition of the permeability transition in CNS mitochondria. J. Neurosci. 2000, 20, 8229-8237.
33. Kowalczyk, J.E.; Zablocka, B. [Protein kinases in mitochondria]. Postep. Biochem. 2008, 54, 209-216.
34. Antico Arciuch, V.G.; Alippe, Y.; Carreras, M.C.; Poderoso, J.J. Mitochondrial kinases in cell signaling: Facts and perspectives. Adv. Drug Deliv. Rev. 2009, 61, 1234-1249.
35. Lopez, D.; Fischbach, M.A.; Chu, F.; Losick, R.; Kolter, R. Structurally diverse natural products that cause potassium leakage trigger multicellularity in Bacillus subtilis. Proc. Natl. Acad. Sci. USA 2009, 106, 280-285.
36. Zhang, A.; Sun, H.; Wang, X. Recent advances in natural products from plants for treatment of liver diseases. Eur. J. Med. Chem. 2013, 63, 570-577.
37. McEwen, M.L.; Sullivan, P.G.; Rabchevsky, A.G.; Springer, J.E. Targeting mitochondrial function for the treatment of acute spinal cord injury. Neurotherapeutics 2011, 8, 168-179.
38. Shi, P.; Wei, Y.; Zhang, J.; Gal, J.; Zhu, H. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis. J. Alzheimer's Dis. 2010, 20, S311-S324.
39. Sun, D.; Wang, B.; Shi, M.; Zhang, Y.X.; Zhou, L.F.; Liu, Z.R.; Wu, Z.L.; Jiang, W.; Han, J.L.; Xiong, L.Z.; et al. Pharmacokinetic, tissue distribution and excretion of ginsenoside-Rd in rodents. Phytomedicine 2012, 19, 369-373.
40. Wang, W.; Wang, G.J.; Xie, H.T.; Sun, J.G.; Zhao, S.; Jiang, X.L.; Li, H.; Lv, H.; Xu, M.J.; Wang, R. Determination of ginsenoside Rd in dog plasma by liquid chromatography-mass spectrometry after solid-phase extraction and its application in dog pharmacokinetics studies. J. Chromatogr. B 2007, 852, 8-14.
41. Deng, Y.H.; Feng, Y.; Zeng, X.; Yang, L.; Liu, Y.M.; Huang, Y.; Sun, J.; Zhou, D.; Liang, W.X. Determination of ginsenoside rd in human plasma by LC/MS/MS. Zhong yao cai/Zhongyaocai/ J. Chin. Med. Mater. 2006, 29, 928-931. (In Chinese)
42. Liu, X.; Xia, J.; Wang, L.; Song, Y.; Yang, J.; Yan, Y.; Ren, H.; Zhao, G. Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: A randomized, double-blind, placebo-controlled, phase II multicenter trial. Eur. J. Neurol. 2009, 16, 569-575.
43. Moore, C.L. Specific inhibition of mitochondrial Ca++ transport by ruthenium red. Biochem. Biophys. Res. Commun. 1971, 42, 298-305.
44. Bernardi, P.; von Stockum, S. The permeability transition pore as a Ca2+ release channel: New answers to an old question. Cell Calcium 2012, 52, 22-27.
45. Crompton, M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 1999, 341, 233-249.
46. Armogida, M.; Nistico, R.; Mercuri, N.B. Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia. Br. J. Pharmacol. 2012, 166, 1211-1224.
47. Gough, D.R.; Cotter, T.G. Hydrogen peroxide: A Jekyll and Hyde signalling molecule. Cell Death Dis. 2011, 2, doi:10.1038/cddis.2011.96.
48. Manning, G.; Whyte, D.B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The protein kinase complement of the human genome. Science 2002, 298, 1912-1934.
49. Bijur, G.N.; Jope, R.S. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J. Neurochem. 2003, 87, 1427-1435.
50. Galli, S.; Arciuch, V.G.A.; Poderoso, C.; Converso, D.P.; Zhou, Q.; de Kier Joffe, E.B.; Cadenas, E.; Boczkowski, J.; Carreras, M.C.; Poderoso, J.J. Tumor cell phenotype is sustained by selective MAPK oxidation in mitochondria. PLoS One 2008, 3, e2379.
51. Gergalova, G.; Lykhmus, O.; Komisarenko, S.; Skok, M. α7 nicotinic acetylcholine receptors control cytochrome c release from isolated mitochondria through kinase-mediated pathways. Int. J. Biochem. Cell Biol. 2014, 49, 26-31.
52. Chao, X.; Zhou, J.; Chen, T.; Liu, W.; Dong, W.; Qu, Y.; Jiang, X.; Ji, X.; Zhen, H.; Fei, Z. Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Brain Res. 2010, 1363, 206-211.
53. Chen, T.; Cao, L.; Dong, W.; Luo, P.; Liu, W.; Qu, Y.; Fei, Z. Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK/ERK pathway. Neurochem. Res. 2012, 37, 983-990.
54. Chen, T.; Zhang, L.; Qu, Y.; Huo, K.; Jiang, X.; Fei, Z. The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway. Int. J. Mol. Med. 2012, 29, 630-636.
55. Zhang, X.; Shi, M.; Bjoras, M.; Wang, W.; Zhang, G.; Han, J.; Liu, Z.; Zhang, Y.; Wang, B.; Chen, J.; et al. Ginsenoside Rd promotes glutamate clearance by up-regulating glial glutamate transporter GLT-1 via PI3K/AKT and ERK1/2 pathways. Front. Pharmacol. 2013, 4, doi:10.3389/fphar.2013.00152.
56. Wang, Y.; Li, X.; Wang, X.; Lau, W.; Xing, Y.; Zhang, X.; Ma, X.; Gao, F. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3beta signaling and inhibition of the mitochondria-dependent apoptotic pathway. PLoS One 2013, 8, e70956.
57. Sussman, M.A. Mitochondrial integrity: Preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte. Expert Rev. Cardiovasc. Ther. 2009, 7, 929-938.
58. Miyamoto, S.; Murphy, A.N.; Brown, J.H. Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue. J. Bioenerg. Biomembr. 2009, 41, 169-180.
59. Zhang, X.; Shi, M.; Ye, R.; Wang, W.; Liu, X.; Zhang, G.; Han, J.; Zhang, Y.; Wang, B.; Zhao, J. et al. Ginsenoside Rd attenuates Tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia. Neurochem. Res. 2014, doi:10.1007/s11064-014-1321-3.
60. Zhu, Y.; Yang, G.Y.; Ahlemeyer, B.; Pang, L.; Che, X.M.; Culmsee, C.; Klumpp, S.; Krieglstein, J. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 2002, 22, 3898-3909.
61. Kuroki, Y.; Fukushima, K.; Kanda, Y.; Mizuno, K.; Watanabe, Y. Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus. Eur. J. Neurosci. 2001, 13, 472-476.
62. Guerra, B.; Diaz, M.; Alonso, R.; Marin, R. Plasma membrane oestrogen receptor mediates neuroprotection against beta-amyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cells. J. Neurochem. 2004, 91, 99-109.
63. Cecatto, C.; Amaral, A.U.; Leipnitz, G.; Castilho, R.F.; Wajner, M. Ethylmalonic acid induces permeability transition in isolated brain Mitochondria. Neurotox. Res. 2014, doi:10.1007/s12640-014-9460-5.
64. Yu, Z.; Liu, N.; Li, Y.; Xu, J.; Wang, X. Neuroglobin overexpression inhibits oxygen-glucose deprivation-induced mitochondrial permeability transition pore opening in primary cultured mouse cortical neurons. Neurobiol. Dis. 2013, 56, 95-103.
65. Gergalova, G.; Lykhmus, O.; Kalashnyk, O.; Koval, L.; Chernyshov, V.; Kryukova, E.; Tsetlin, V.; Komisarenko, S.; Skok, M. Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria. PLoS One 2012, 7, e31361.